FeaturedNeurologyNeuroscience·April 9, 2026·10 min readAI Reveals Loneliness and Insomnia as Risks for DiabetesA 17-year study using AI "digital twins" reveals that loneliness, insomnia, and poor mental health raise Type 2 diabetes risk by 78% when combined. The model suggests mental health is a stronger predictor than diet.Read More
FeaturedNeurologyNeuroscience·April 9, 2026·7 min readMicronutrients Could Stop Brain Bleeding in Alzheimer’s TreatmentResearchers have found that combining Alzheimer’s medications with molecules derived from grapes and turmeric is more effective and safer than current treatments, potentially reducing risks of brain swelling.Read More
FeaturedNeurologyNeuroscience·April 8, 2026·10 min readBrain’s Unique Wiring Determines How Alzheimer’s SpreadsA 10-year study proves that Alzheimer’s tau tangles spread via an individual's unique neural connections. The findings confirm that targeting tau as it travels between synapses could halt the disease's progression.Read More
FeaturedNeurologyNeurosciencePsychology·April 8, 2026·6 min readGlass Half Full: Optimism Lowers Your Dementia RiskA 14-year study of 9,000 adults finds that high optimism reduces dementia risk by 15%. The benefit remains consistent across racial and ethnic groups.Read More
FeaturedGeneticsNeurologyNeuroscience·April 7, 2026·6 min readSingle Immune Switch Drives Both Arthritis and Alzheimer’sResearchers identify TREM-1 as a potent amplifier of the innate immune system. The review suggests that targeting this receptor could provide new treatments for sepsis, arthritis, and Alzheimer’s.Read More
FeaturedGeneticsNeurologyNeuroscience·April 3, 2026·9 min readAlzheimer’s Risk Gene Shrinks NeuronsThe APOE4 gene triggers a protein called Nell2, which shrinks neurons and causes brain hyperactivity. Lowering Nell2 levels reversed these effects in mice, offering a new target for early Alzheimer's intervention.Read More
FeaturedNeurologyNeurosciencePain·April 2, 2026·9 min readBrain Circuit That “Invents” Chronic Pain IdentifiedNeuroscientists have identified a dedicated brain circuit responsible for chronic pain. By silencing this loop, researchers were able to end pain hypersensitivity in mice without affecting their ability to feel necessary, acute pain.Read More
FeaturedNeurologyNeuroscience·April 2, 2026·7 min readMono Linked to a Threefold Increase in MS RiskA study of nearly 19,000 people reveals that a history of infectious mononucleosis (mono) triples the risk of developing Multiple Sclerosis. The findings suggest that preventing Epstein-Barr virus infections could be a key strategy in reducing MS cases.Read More
FeaturedNeurologyNeuroscience·April 1, 2026·8 min readResearchers Unlock the Key to Axon RegenerationResearchers identified the AHR protein as a "molecular brake" that stops nerve regrowth after injury. Inhibiting AHR shifts neurons from a stress-management state to a regenerative state, offering a new path for treating spinal cord injuries.Read More
FeaturedNeurologyNeurosciencePain·April 1, 2026·9 min readHigh-Potency Opioid Relieves Pain Without the RisksResearchers have engineered a novel nitazene-based opioid, DFNZ, that provides potent pain relief without causing respiratory depression or addiction. The "superagonist" drug could revolutionize treatment for chronic pain and opioid use disorder.Read More
FeaturedGeneticsNeurologyNeuroscience·April 1, 2026·8 min readWhy MS Attacks the Brain’s “Thinking” CentersA major study reveals that MS causes permanent brain damage by breaking down the DNA of "CUX2" neurons in the gray matter. This discovery marks a shift in MS research toward protecting neuronal DNA from inflammatory stress.Read More
FeaturedGeneticsNeurologyNeuroscience·March 31, 2026·8 min readUsing “Left-Handed” Proteins to Block Alzheimer’sResearchers designed a "mirror-image" protein that disables amyloid-beta, the primary cause of Alzheimer's plaques. By exploiting molecular chirality, the team created a "right-handed" interceptor that prevents toxic proteins from clumping.Read More
